Downregulation of the mitochondrial tRNA-derived fragment mt-tRF-Leu<sup>TAA</sup> enhances skeletal muscle insulin sensitivity
The mitochondrial tRNA-derived fragment mt-tRF-Leu<sup>TAA</sup> couples mitochondrial metabolism to insulin secretion. While its role in pancreatic β-cell function is well established, its broader impact on multiorgan glucose homeostasis remains unclear. In insulin target tissues, the presence, regulation, and mechanism of action of mt-tRF-Leu<sup>TAA</sup> are entirely unexplored. This study addresses this gap by investigating the impact of diet, nutritional status, and diabetes on mt-tRF-Leu<sup>TAA</sup> regulation and by assessing its role in insulin sensitivity. We examined mt-tRF-Leu<sup>TAA</sup> levels in different insulin target tissues, including skeletal muscle, liver, and epididymal white adipose tissue, of rodents under physiological and pathological conditions. In skeletal muscle myotubes, we combined subcellular fractionation, antisense oligonucleotide-mediated knockdown, and glucose uptake assays to determine mt-tRF-Leu<sup>TAA</sup>'s mitochondrial localization and its influence on insulin sensitivity. mt-tRF-Leu<sup>TAA</sup> levels in mouse skeletal muscle decreased twofold in response to fasting. In myotubes, this tRNA fragment was enriched in mitochondria, and its downregulation enhanced glucose uptake. While the levels of mt-tRF-Leu<sup>TAA</sup> remained unchanged in insulin target tissues of diabetic mice, we observed a skeletal muscle-specific downregulation of mt-tRF-Leu<sup>TAA</sup> in young adult rats exhibiting insulin hypersensitivity. This study identifies mt-tRF-Leu<sup>TAA</sup> as a candidate regulator of skeletal muscle insulin response. By modulating both insulin secretion and action, mt-tRF-Leu<sup>TAA</sup> appears to play a notable role in systemic metabolic control and may represent a promising target for diabetes treatment.<b>NEW & NOTEWORTHY</b> Fasting downregulates levels of mt-tRF-Leu<sup>TAA</sup> in skeletal muscle. While this small RNA fragment is enriched in the mitochondria of myotubes, inhibition of mt-tRF-Leu<sup>TAA</sup> in myotubes enhances insulin-mediated glucose uptake. Consistently, mt-tRF-Leu<sup>TAA</sup> is also downregulated in the skeletal muscle of insulin-hypersensitive rats. Together, these findings highlight mt-tRF-Leu<sup>TAA</sup> as a key metabolic regulator influencing both insulin secretion and action.
Authors
- Romano Regazzi (ORCID: https://orcid.org/0000-0002-9773-2915)
- Véronique Menoud
- Chris Donnelly (ORCID: https://orcid.org/0000-0002-5392-7876)
- Bengt Kayser (ORCID: https://orcid.org/0000-0002-9776-7501)
- Cécile Jacovetti
Institutions
- University of Lausanne (CH)
Publication Details
- Journal
- American Journal of Physiology-Endocrinology and Metabolism
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1152/ajpendo.00284.2025
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung